Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2012
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2465501A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of preparation
06/20/2012EP2465358A1 Method for manufacturing a functional gel
06/20/2012EP2464642A1 Method of promoting apoptosis and inhibiting metastasis
06/20/2012EP2464385A2 Photochemical internalization method
06/20/2012EP2464384A2 Photosensitizing compositions
06/20/2012EP2464337A1 Pharmaceutical composition and administrations thereof
06/20/2012EP1857544B1 Pluripotent stem cell derived from cardiac tissue
06/20/2012EP1496053B1 Kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative
06/20/2012EP1311267B1 A retroviral immunotherapy
06/20/2012CN1835766B Osteogenesis promoter
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102505006A Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof
06/20/2012CN102499981A Compositions and methods for topical application and transdermal delivery of botulinum toxins
06/20/2012CN102499925A Neutrophilic granulocyte elastase inhibitor
06/20/2012CN101555212B Synthesized micromolecule compound capable of conveying bioactivator and application thereof
06/19/2012US8202860 Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
06/19/2012US8202845 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2539469C Pyridylacetylenes for use as radiotracers and imaging agents
06/19/2012CA2469939C Method of inducing ovulation using a non-polypeptide camp level modulator
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/19/2012CA2319872C Pharmaceutical composition for the treatment of hepatocellular carcinoma
06/14/2012WO2012078855A1 Substituted pyrazolopyrimidines as glucocerebrosidase activators
06/14/2012WO2012077811A1 Galectin 9-secreting cell, production method for same, and application for same
06/14/2012WO2012077775A1 Composition for treatment of cancer pain and use thereof
06/14/2012WO2012076877A1 Hydantoin derivatives useful as kv3 inhibitors
06/14/2012WO2012076429A1 Treating conditions associated with increased eotaxin with 25-hydroxyvitamin d3
06/14/2012US20120151612 Non-surgical approach to prevent and correct craniofacial malformations during development
06/14/2012US20120149771 Method for treating airway hyper-responsiveness with lipoxin analogs
06/14/2012US20120149755 Antisense oligonucleotide modulation of raf gene expression
06/14/2012US20120149702 Inhibitors of cellular necrosis
06/14/2012US20120149689 Method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120149649 Short-chain cationic polyamino acid and use thereof
06/14/2012US20120149642 Fibrosis inhibitor for implanted organ
06/14/2012US20120149044 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
06/14/2012US20120149025 Screening Methods for Human Embryonic Stem Cells
06/14/2012US20120148632 Methods for complex tissue engineering
06/14/2012US20120148609 Intracoronary device and method of use thereof
06/14/2012US20120148556 Formulations for Lysosomal Enzymes
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148540 Proliferated cell lines and uses thereof
06/14/2012US20120148537 Methods to enhance cell migration and engraftment
06/14/2012US20120148522 Biocompatible Polyelectrolyte Complexes and Methods of Use
06/14/2012CA2820642A1 Galectin-9-secreting cell, and production method and use of the same
06/14/2012CA2820362A1 Substituted pyrazolopyrimidines as glucocerebrosidase activators
06/14/2012CA2817205A1 Hydantoin derivatives useful as kv3 inhibitors
06/13/2012EP2463286A1 Benzyl piperidine compound
06/13/2012EP2463276A1 Nitrogenous-ring acylguanidine derivative
06/13/2012EP2462943A1 Dipeptidyl peptidase-4 inhibitor
06/13/2012EP2399927A9 Novel compound, phosphorylation inhibitor, insulin resistance improving agent, agent to prevent or to treat diabetes, and screening method
06/13/2012EP2200596B1 Method of treating gaucher disease
06/13/2012EP1944291B1 Optically active cyclic alcohol compound and method for producing same
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1449542B1 Hgf as genetic remedy for parkinson's disease
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1297017B1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
06/13/2012CN1615890B Use of vitamin d compounds
06/13/2012CN102498105A Bicyclic compound and use thereof for medical purposes
06/13/2012CN102498101A Aniline compounds
06/13/2012CN102498097A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498096A Indole derivative and pharmacologically acceptable salt thereof
06/13/2012CN102498095A Indoline derivatives
06/13/2012CN102498091A Glycine compound
06/13/2012CN102497877A Modified erythropoietin to which water-soluble long-chain molecule is added
06/13/2012CN102497875A Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
06/13/2012CN102497859A Pharmaceutical composition and administrations thereof
06/13/2012CN102488881A Compound propolis composition for promoting pig growth and fattening as well as its preparation method
06/13/2012CN102145067B Traditional Chinese medicine capsule for treating bone marrow suppression caused by highly active antiretroviral therapy (HAART) for AIDS (acquired immure deficiency syndrome)
06/13/2012CN102119983B Traditional Chinese medicine composition for preventing and treating heat stress of livestock and poultry
06/13/2012CN101721556B Medicament composition with anti-inflammatory function and preparation method thereof
06/13/2012CN101641117B Pharmaceutical composition
06/13/2012CN101406469B Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/12/2012US8198483 Phenethanolamine derivatives for treatment of respiratory diseases
06/12/2012US8198334 Methods for modulating macrophage proliferation in ocular disease using polyamine analogs
06/12/2012US8198323 Curcumin analogues and uses thereof
06/12/2012US8198295 Benzonaphthyridines
06/12/2012US8198286 Sodium channel blockers
06/12/2012US8198234 Methods of suppressing microglial activation
06/12/2012US8198078 Fucosyl transferase gene
06/12/2012US8197848 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
06/12/2012CA2681962C Methods of administering epothilone analogs for the treatment of cancer
06/12/2012CA2663965C Pyrazolopyrimidine derivative and use thereof as an anticancer agent
06/12/2012CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor
06/12/2012CA2262756C A tumor necrosis factor related ligand
06/07/2012WO2012074129A1 Peptide with safer secondary structure, peptide library, and production methods for same
06/07/2012WO2012074110A1 Orally disintegrating tablet
06/07/2012WO2012074085A1 Marker for determination of sensitivity to triplet combination anti-cancer agent
06/07/2012WO2012074037A1 Breast enhancement accelerator
06/07/2012WO2012073627A1 Tie2 ACTIVATOR, VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, ANTI-ANGIOGENIC AGENT, AGENT FOR MATURING BLOOD VESSELS, AGENT FOR NORMALIZING BLOOD VESSELS, AGENT FOR STABILIZING BLOOD VESSELS, AND PHARMACEUTICAL COMPOSITION
06/07/2012WO2012071772A1 :grape wine of nutritional enhancement
06/07/2012WO2011132075A3 A hydrate of a cyclohexanamine derivative
06/07/2012US20120142777 Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
06/07/2012US20120142769 Methods for treating or preventing fatigue
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 1564